Table 2 Background of aged patients and younger conterpart
| Â | Â | Â | Â | Aged (80-) | Â | Control (-79) | Â |
|---|---|---|---|---|---|---|---|
| Â | Â | Â | Â | (N = 21) | Â | (N = 226) | Â |
Age | Age | Median (Range) | Â | 81 (80-89) | Â | 56 (18-79) | Â |
Gender | Male | Â | Â | 9 | (43%) | 101 | (45%) |
| Â | Female | Â | Â | 12 | (57%) | 125 | (55%) |
T classification | T1 | Â | Â | 2 | (10%) | 30 | (13%) |
| Â | T2 | Â | Â | 14 | (67%) | 146 | (65%) |
| Â | T3 | Â | Â | 5 | (24%) | 50 | (22%) |
|  | Long diameter | (mm) |  | 30 ± 8 |  | 26 ± 9 |  |
|  | Short diameter | (mm) |  | 18 ± 7 |  | 18 ± 8 |  |
|  | Thickness | (mm) |  | 11 ± 6 |  | 9 ± 6 |  |
Source | Ra-226 | Â | Â | 4 | (19%) | 72 | (32%) |
| Â | Ir-192 | Â | Â | 12 | (71%) | 120 | (63%) |
| Â | Au-198 | Â | Â | 1 | (5%) | 0 | (0%) |
| Â | MS-HDR | Â | Â | 4 | (19%) | 34 | (15%) |
External radiotherapy | Brachytherapy only | Â | Â | 13 | (80%) | 165 | (73%) |
| Â | Combined with external radiotherapy | Â | 8 | (20%) | 61 | (27%) | |
Prescribed dose | Brachytherapy | Median (Range)(Gy) | LDR | 70 (54-85) | Â | 70 (50-112) | Â |
| Â | Â | Â | HDR | 54 (32-60) | Â | 60 (42-60) | Â |
| Â | External radiotherapy | Median (Range)(Gy) | LDR | Â | 30 (12-60) | Â | |